AttendMe Owl Logo
AttendMe
Evidence Evolution
Evidence Evolution
Landmark TrialRCTRandomized Controlled Trial

Neurostimulation for Parkinson's Disease with Early Motor Complications

New England Journal of Medicine2013IF: 25.4

W.M. Michael Schuepbach, Jörn Rau, Karina Knudsen, Jens Volkmann, Paul Krack, Lars Timmermann, Thomas D. Hälbig, Helke Hesekamp, Soledad Navarro, Niklaus Meier, Daniela Falk, H. Maximilian Mehdorn, Steffen Paschen, Mohammed Maarouf, Michael T. Barbe, Gereon R. Fink, Andreas Kupsch, Doreen Gruber, Gerd‐Helge Schneider, Éric Seigneuret, Andrea Kistner, Patrick Chaynes, Fabienne Ory‐Magne, Christine Brefel Courbon, Jan Vesper, Alfons Schnitzler, Lars Wojtecki, J.L. Houéto, B. Bataille, David Maltête, Philippe Damier, Sylvie Raoul, F. Sixel-Doering, D. Hellwig, Alireza Gharabaghi, Rejko Krüger, M. Pinsker, F. Amtage, João Marcos Gomes Regis, Tatiana Witjas, Stéphane Thobois, Patrick Mertens, M. Kloss, A. Hartmann, Wolfgang H. Oertel, Bart Post, Hans Speelman, Yves Agid, Carmen Schade‐Brittinger, Günther Deuschl

PMID: 23406026View on PubMedDOI

Abstract

Subthalamic stimulation was superior to medical therapy in patients with Parkinson's disease and early motor complications. (Funded by the German Ministry of Research and others; EARLYSTIM ClinicalTrials.gov number, NCT00354133.).

Specialty

Neurosurgery

Featured in Evidence Evolutions